Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | GYS1 | P13807 | 6/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2052707 | 0.87 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1CA2NPSR1GYS1 | |
| SCHEMBL24313493 | 0.85 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1FFAR2CA2NPSR1 | |
| SCHEMBL13369767 | 0.83 | FFAR2 (0.62) | ALDH1A1L3MBTL1FFAR2 | |
| SCHEMBL5036076 | 0.83 | CA2 (0.64) | ALDH1A1L3MBTL1CA2NPSR1TDP1 | |
| SCHEMBL1750558 | 0.83 | CA2 (0.64) | ALDH1A1L3MBTL1CA2NPSR1TDP1 | |
| SCHEMBL13229 | 0.80 | CA2 (0.67) | ALDH1A1L3MBTL1CA2NPSR1TDP1 | |
| SCHEMBL28789388 | 0.80 | CA2 (0.67) | ALDH1A1L3MBTL1CA2NPSR1TDP1 | |
| SCHEMBL13230 | 0.80 | CA2 (0.67) | ALDH1A1L3MBTL1CA2NPSR1TDP1 | |
| SCHEMBL6787910 | 0.80 | CA2 (0.75) | ALDH1A1L3MBTL1CA2NPSR1TDP1 | |
| SCHEMBL5537767 | 0.80 | CA2 (0.75) | ALDH1A1L3MBTL1CA2NPSR1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011073376-A1 | PYRROLIDINE OR THIAZOLIDINE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERSAS AS AGONISTS OF G- PROTEIN COUPLED RECEPTOR 43 (GPR43) | EUROSCREEN S.A. (BE) | 2011-06-23 | — | — | WO | disclosed |